In this episode of the Express Pharma – Nutrify Today Boardroom series, Dr Raktim Chattopadhyay, Founder & CEO, Esperer Nutrition speaks on the need for in-depth clinical research and validation backing all products from Esperer Nutrition, which sets them apart as disease-specific nutritional interventions to help patients and doctors manage and recover from cancer, and non-communicable diseases (NCDs). As a Member of the Task Force, Nutraceutical Council to PSA office, Government of India, he also comments on how enabling policies can elevate India’s Nutraceuticals sector on the global stage. With Esperer Nutrition expanding to other therapeutic areas, he explains how new age tools like AI and ML could potentially disrupt the nutraceutical sector.
The post appeared first on .